Host DNA released in response to aluminum adjuvant enhances MHCII mediated antigen presentation and prolongs CD4 T cell interactions with dendritic cells. (P4244)

Amy McKee,Matthew Burchill,Munks Michael,Lei Jin,John Kappler,Rachel Friedman,Jordan Jacobelli,Philippa Marrack

DOI: https://doi.org/10.4049/jimmunol.190.supp.47.10

2013-05-01

The Journal of Immunology

Abstract:Abstract Many vaccines include aluminum salts (alum) as adjuvants in spite of little knowledge of alum’s functions. Host DNA rapidly coats injected alum. Here we further investigated the mechanism of alum and DNA’s adjuvant function. Our data show that DNAse co-injection reduces CD4 T cell priming by intramuscularly injected antigen plus alum. This effect is partially replicated in mice lacking STING, a mediator of cellular responses to cytoplasmic DNA. Others have shown that DNAse treatment impairs alum induced DC migration from the peritoneal cavity to the draining LN. However our data shows that DNAse does not affect accumulation of, nor expression of costimulatory proteins on, antigen loaded dendritic cells in lymph nodes draining injected muscles, the site by which most human vaccines are administered. DNAse does inhibit prolonged T cell-DC conjugate formation and antigen presentation between antigen+ DCs and antigen specific CD4 T cells following intramuscular injection. Thus, from the muscle, an immunization site that does not require host DNA to promote migration of inflammatory DC, alum acts as an adjuvant by introducing host DNA into the cytoplasm of antigen-bearing DCs, where it engages receptors that promote MHC II presentation and better DC-T cell interactions.

immunology